HyperClear:前立腺肥大症のレーザー治療
前立腺肥大症(BPH)を精密に治療するために設計された先進のレーザーシステムで、効果的な組織除去、尿流の改善、ダウンタイムの最小化を実現し、患者さんの治療成績を向上させます。
HyperClear represents an innovative laser therapy system designed to effectively remove surplus prostatic tissue in benign prostatic hyperplasia (BPH). Leveraging the LIFE (Laser-Induced Fiber Enucleation) method, HyperClear applies precise laser energy via a flexible fiber placed transurethrally to the obstructive zone, ablating the excess prostate tissue responsible for lower urinary tract symptoms (LUTS). This approach may be performed outpatient—often with local anesthesia—enhancing patient comfort while maintaining efficacy and safety.
High-Precision Laser Fiber
- Optimized Energy Delivery: The laser fiber is advanced through the urethra to the blocked area, targeting surplus prostate tissue while minimizing collateral damage.
- LIFE Method: Focused on selective tissue vaporization or enucleation, ensuring clean resection planes and predictable tissue removal.
Outpatient Feasibility
- Local Anesthesia: Allows many patients to undergo the procedure without the risks or recovery times associated with general anesthesia.
- Rapid Recovery: Less invasive than conventional transurethral resections, potentially reducing hospital stays and improving patient throughput.
Real-Time Visualization
- Precise Tissue Identification: Endoscopic imaging guides the laser fiber to the obstructive tissue, ensuring thorough clearance of the prostatic urethra.
- Controlled Ablation: The surgeon can finely tune laser energy to match the tissue’s vascularity and density, limiting the risk of deep thermal damage.
Efficient & Gentle Tissue Removal
- Targeted Laser Ablation: Precisely removes hyperplastic prostate segments that hinder urine flow, preserving healthy tissue zones.
- Hemostatic Effect: Laser energy also cauterizes small vessels during tissue vaporization, reducing intraoperative bleeding.
臨床上の利点と応用
Benign Prostatic Hyperplasia (BPH)
- Symptomatic Relief: Alleviates classic LUTS such as frequent urination, weak urine stream, and prolonged emptying times.
- Patient Selection: Suited for patients with moderate-to-severe BPH who seek a less invasive alternative to standard TURP or open prostatectomy.
Minimal Invasiveness
- Outpatient Possibility: Potentially performed under local anesthesia, minimizing hospitalization and facilitating early mobilization.
- Lower Bleeding Risk: Laser-based enucleation or vaporization significantly reduces hemorrhage compared to mechanical resection methods.
患者体験の向上
- Shorter Convalescence: Many patients resume daily activities sooner, with less postoperative discomfort or catheterization durations.
- Reduced Need for General Anesthesia: Local or spinal anesthesia lessens systemic risks, beneficial for older or comorbid patients.
Technical Specifications
仕様 | 詳細 / 価値 |
製品名 | CytroFIX®スーペリア・クラビキュラ・プレート |
素材 | High-Purity Titanium Alloy (e.g., Ti-6Al-4V ELI) |
Plate Profile | Low-profile, contoured for superior clavicle placement |
Locking Mechanism | Locking or non-locking titanium screws; optional variable-angle locking |
Screw Diameter | 2.7 mm or 3.5 mm (titanium cortical screws, depending on hole specification) |
Plate Thickness | ~2.0–2.5 mm (minimized profile) |
Hole Array | Multiple holes for bridging, compression, or combined fixation patterns |
ラジオパシティ | Titanium visible on fluoroscopy (optional etched markers) |
不妊症 | Provided non-sterile (autoclavable) or sterile, single use or reusable instrumentation (verify product line) |
賞味期限 | Indefinite if stored properly; reusable within recommended inspection cycles |
臨床適応症 | Midshaft/lateral clavicle fractures requiring superior plating, osteotomies, nonunion correction |
Regulatory Compliance | Conforms to ISO 13485, CE/FDA (region-specific), meets orthopedic implant standards |
Size & Ordering Matrix
Plate Length (mm) | Hole Count | Curvature | Compatible Screw | 商品コード | 備考 |
60 | 4 | Mild Superior Bend | 2.7 mm Locking/Non-Locking | CFX-SCL-60-4-27-Ti | Shorter plate for smaller fractures in lateral or mid-shaft |
70 | 5 | Mild Superior Bend | 2.7 mm Locking/Non-Locking | CFX-SCL-70-5-27-Ti | Extended coverage for mild to moderate fractures |
80 | 5 | Moderate Superior Bend | 2.7 or 3.5 mm Locking | CFX-SCL-80-5-MX-Ti | Bridges midshaft fractures with variable-angle options |
90 | 6 | Moderate Superior Bend | 3.5 mm Locking/Non-Locking | CFX-SCL-90-6-35-Ti | For larger or multi-fragment fractures requiring robust support |
100 | 7 | Enhanced Superior Contour | 3.5 mm Locking/Non-Locking | CFX-SCL-100-7-35-Ti | Accommodates more complex or extended fracture lines |
110 | 8 | Enhanced Superior Contour | 3.5 mm Locking/Non-Locking | CFX-SCL-110-8-35-Ti | Longest plate design for challenging multi-segment fractures |
関連商品
-
ThermoEdge RFA:多用途ラジオ波焼灼プラットフォーム
続きを読む多用途のラジオ波焼灼システムは、以下のような多様な病態を正確かつ効果的に管理するために設計されている。 月経、子宮筋腫(筋腫)、 そして 低侵襲で無血の切除術 の 肝臓および腎臓組織嚢胞の治療と同様である。
-
UroGuideガイドワイヤー
続きを読む精密に設計されたガイドワイヤーは、泌尿器科手術の際に卓越したコントロール性と柔軟性を提供し、スムーズなナビゲーションと尿路へのアクセス向上を実現する。
-
統合関節鏡ポンプ
続きを読むについて 統合関節鏡ポンプ は セーフ, 信頼できるそして ユーザーフレンドリー 流体管理ソリューション 継続的, パルスフリー 管理 関節内洗浄 そして 膨張圧 を通して すべて 関節鏡手術の段階。
-
Atlas冠動脈ステントグラフトシステム
続きを読むA 被覆冠動脈ステント 提供システム 腔外 封入 ミシン目 または 偽動脈瘤冠動脈の開存性を維持しながら、血管外滲出を防ぐ。